Lars Devisscher

University of Antwerp — Belgium

Medicine · Health Sciences

6h-index439citations7works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ferroptosis and cancer prognosis(3), Cancer, Lipids, and Metabolism(3), Cell death mechanisms and regulation(2), Drug Transport and Resistance Mechanisms(2), Cancer-related Molecular Pathways(2)

Publications7 total

Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy
Journal of Medicinal Chemistry·2018· 161 cited
Novel third-generation ferrostatins protect against acute iron poisoning-induced organ injury
Free Radical Biology and Medicine·2018
Novel drug discovery strategies for atherosclerosis that target necrosis and necroptosis
Expert Opinion on Drug Discovery·2018· 32 cited
Tozasertib Analogues as Inhibitors of Necroptotic Cell Death
Journal of Medicinal Chemistry·2018· 47 citedOpen Access
RIPK1-dependent cell death: a novel target of the Aurora kinase inhibitor Tozasertib (VX-680)
Cell Death and Disease·2018· 58 citedOpen Access
Synthesis of 1,3,6‐Trisubstituted Azulenes Based on the 1‐Acyloxyazulene Scaffold
European Journal of Organic Chemistry·2016· 9 cited
Novel Ferroptosis Inhibitors with Improved Potency and ADME Properties
Journal of Medicinal Chemistry·2015· 132 cited

Frequent Co-authors

Sam Hofmans(6), Koen Augustyns(6), Peter Vandenabeele(5), Pieter Van der Veken(4), Tom Vanden Berghe(3), Dries Van Rompaey(2), Kenneth Goossens(2), Hans De Winter(2), Behrouz Hassannia(2), Sofie Martens(2), Vera Goossens(2), Nozomi Takahashi(2), Samya Van Coillie(1), Eline Meul(1), Louis Maes(1), Sophie Lyssens(1), Jurgen Joossens(1), Polien Claeys(1), Marnik Vuylsteke(1), Tatyana Divert(1)